Express Healthcare
Home  »  News  »  Heroic deed of Jyoti Kumari applauded by Mankind Pharma

Heroic deed of Jyoti Kumari applauded by Mankind Pharma

0 657
Read Article

Kumari a fifteen year old cycled 1,200 kms with her ailing father riding pillion, from Gurugram to her home in Bihar amidst lockdown

Amidst multiple tales of the struggle for survival in the ongoing global COVID-19 crisis, Mankind Pharma has been supporting the community and frontline workers fighting against the deadly virus. With similar thoughts , the company has now stepped up and applauded the heroic tale of Jyoti Kumari by offering Rs 1 lakh aid to the lion-hearted girl.

Mankind has supported 15-year-old Jyoti Kumari, who cycled 1,200 kms with her ailing father riding pillion, from Gurugram to her home in Bihar amidst the lockdown.

Rajeev Juneja, CEO Mankind Pharma, stated, “Mankind Pharma is standing by everyone in this unprecedented crisis. Mankind salutes the selfless love and commitment of Jyoti Kumari for her parents . She had cycled for eight long days to cover 1200 km journey from Gurugrm (Haryana) to Darbhanga ( Bihar) to help her ill father reach home. We are proud of her as she overcame all hurdles to achieve her aim. Her mental toughness and sheer determination must be rewarded. We would like to support her in a manner that will help her achieve greater heights in life. We hope with our little support she can fulfil her dreams and become a role model for others to follow.”

Jyoti Kumari said, “I thank Mankind Pharma for their support and look forward to completing my studies. This has motivated me to pursue my goal and also take care of my family.”  

Leave A Reply

Your email address will not be published.

Attend an exclusive webinar to know more about biomarkers in diagnosis & therapy management of heart failure.
Register Now
close-image
 Introducing Smart Autoinjector: Changing the paradigm of usability, cost & size
Know More?
close-image
Are you looking for ICP-MS which can increase productivity and remove time trap from your analysis?
Know More
close-image